Cite
Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 treatment.
MLA
Gamal, Sherif, et al. “Simultaneous Spectrophotometric Determination of Recombined Sofosbuvir, Ledipasvir and Paracetamol Together as Commonly Repurposed Drugs for COVID-19 Treatment.” Future Journal of Pharmaceutical Sciences, vol. 9, no. 1, Aug. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s43094-023-00548-3.
APA
Gamal, S., Mandour, A. A., Mohamed, G. G., Salih, S. A., & Ahmed, D. A. (2023). Simultaneous spectrophotometric determination of recombined sofosbuvir, ledipasvir and paracetamol together as commonly repurposed drugs for COVID-19 treatment. Future Journal of Pharmaceutical Sciences, 9(1), 1–10. https://doi.org/10.1186/s43094-023-00548-3
Chicago
Gamal, Sherif, Asmaa A. Mandour, Gehad G. Mohamed, Said A. Salih, and Dina A. Ahmed. 2023. “Simultaneous Spectrophotometric Determination of Recombined Sofosbuvir, Ledipasvir and Paracetamol Together as Commonly Repurposed Drugs for COVID-19 Treatment.” Future Journal of Pharmaceutical Sciences 9 (1): 1–10. doi:10.1186/s43094-023-00548-3.